The Food and Drug Administration (FDA) rendered a public health advisory warning recently in which it made absolutely clear that patients and physicians should discuss the potential effects of Zoloft and similar antidepressant SSRIs (selective serotonin reuptake inhibitors) during pregnancy. In its advisory, the FDA specifically cited studies which identified the very real risk that newborns exposed to Zoloft and other SSRIs might develop persistent pulmonary hypertension (PPHN) and other birth defects.
The warnings from the FDA and respected medical journals about Zoloft and other SSRIs have been clear. Despite this, some physicians have failed in their duty to counsel their patients. Additionally, some experts question whether drug manufacturers appropriately responded to the PPHN risk, pointing to insufficiently informative package labels.
The attorneys at Fears Nachawati understand that the physical pain and mental anguish many families suffer today as a result of Zoloft is considerable. These victims deserve justice and our professionals work tirelessly to make sure that they get it. Was your child born with SSRI-related birth defects? Your family doesn’t have to suffer alone. Put our expertise and experience to work fighting for your rights. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for you!